Jaundice Meter Market Is Expected To Show Impressive Growth Rate Between 2021 To 2028
A Jaundice meter measures bilirubin, a yellow pigment found in the skin and other mucous membranes. Due to the hyperbilirubinemia disease, the body's bilirubin levels rise, which further causes jaundice. A jaundice metre, also known as a bilirubinometer, is frequently used to measure neonatal jaundice. It is a real-time, affordable, and non-invasive bilirubin screening instrument.
The Jaundice Meter Market is anticipated to develop due to technological advancements. For instance, the American Academy of Pediatrics, August 2017, states that BiliCam is a smartphone-based non-invasive medical technology that uses the camera on the device to monitor yellow discoloration of the skin caused by excessive bilirubin deposition. On the phone, newborn pictures are gathered in a consistent manner. To estimate the bilirubin level, the colour (strength of yellow discolouration) data from the image are employed.
The Jaundice Meter Market Expansion is anticipated to be hampered by serious injuries brought on by improper usage of the device. For instance, the Food and Drug Administration (FDA) recalled the Jaundice Meter JM-103 and JM-105 models from Draeger Medical Systems in June 2018 due to the fact that many users mistook display messages for out-of-range values for bilirubin using such a system, which can lead to serious injuries like brain damage.
Due to increased development of jaundice metres by major players and partnerships among them, the Jaundice Meter Market in Europe is anticipated to experience spectacular growth. For instance, in 2016, the U.K.-based firm DELTA Medical International was granted distribution rights for M & B Electronic's non-invasive jaundice metres in the U.K. and Ireland. This non-invasive jaundice metre gives quick readings for blood's bilirubin levels and is simple to use. Additionally, a clinical research for the Delta Medical International transcutaneous jaundice metre was conducted in 2017. The results showed a statistical correlation between the transcutaneous measures and serum bilirubin assays.

Comments
Post a Comment